RadiotherapyFDA-approvedSecond-line
Radium-223 dichloride
How it works
Delivers targeted radiation to prostate cancer cells, killing them through ionizing radiation.
Cancer types
Efficacy
In clinical trials, radium-223 dichloride significantly improved overall survival and delayed disease progression in patients with castration-resistant prostate cancer with bone metastases.
Side effects
Moderate
Side effects can be significant and may require dose adjustments or supportive medication, but the treatment is usually continued.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.